| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
118,790,000 |
| Market
Cap: |
42.71(M) |
| Last
Volume: |
19,275,386 |
Avg
Vol: |
8,941,637 |
| 52
Week Range: |
$0.3595 - $0.3595 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Novavax is a biotechnology company that promotes improved global health through the discovery, development and commercialization of vaccines to prevent serious infectious diseases. Co.'s vaccine candidates, including both its coronavirus vaccine candidate, NVX-CoV2373, and its primary influenza vaccine candidate, NanoFlu, are genetically engineered, three-dimensional nanostructures of recombinant proteins critical to disease pathogenesis. NVX-CoV2373 and NanoFlu include the use of Co.'s proprietary Matrix-M™ adjuvant.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
6,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$43,042 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
3 |
| Total Shares Sold |
47,312 |
47,312 |
47,312 |
47,312 |
| Total Sell Value |
$657,637 |
$657,637 |
$657,637 |
$657,637 |
| Total People Sold |
1 |
1 |
1 |
1 |
| Total Sell Transactions |
1 |
1 |
1 |
1 |
| End Date |
2024-02-17 |
2023-11-16 |
2023-05-18 |
2022-05-18 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2021-02-01 |
4 |
OE |
$5.95 |
$272,724 |
D/D |
15,022 |
15,297 |
|
- |
|
| Trizzino John |
EVP, Chief Commercial Officer |
• – – |
2021-01-25 |
4 |
D |
$128.60 |
$9,388 |
D/D |
(73) |
287 |
|
- |
|
| Trizzino John |
EVP, Chief Commercial Officer |
• – – |
2021-01-25 |
4/A |
AS |
$128.60 |
$9,388 |
D/D |
(73) |
287 |
|
- |
|
| Trizzino John |
EVP, CMO and CBO |
• – – |
2021-01-07 |
4 |
AS |
$124.17 |
$62,830 |
D/D |
(506) |
287 |
|
- |
|
| Trizzino John |
EVP, Chief Commercial Officer |
• – – |
2021-01-05 |
4/A |
D |
$116.24 |
$59,399 |
D/D |
(511) |
866 |
|
- |
|
| Trizzino John |
EVP, CMO and CBO |
• – – |
2021-01-05 |
4 |
D |
$116.24 |
$67,884 |
D/D |
(584) |
793 |
|
- |
|
| Trizzino John |
EVP, CMO and CBO |
• – – |
2021-01-05 |
4 |
D |
$116.24 |
$6,858 |
D/D |
(59) |
1,377 |
|
- |
|
| Trizzino John |
EVP, CMO and CBO |
• – – |
2021-01-05 |
4 |
OE |
$5.95 |
$256,243 |
D/D |
13,756 |
1,436 |
|
- |
|
| Trizzino John |
EVP, CMO and CBO |
• – – |
2021-01-05 |
4 |
AS |
$110.25 |
$1,949,522 |
D/D |
(17,407) |
287 |
|
- |
|
| Young James F |
Director |
– • – |
2021-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
|
- |
|
| Douglas Richard |
Director |
– • – |
2020-12-31 |
4 |
OE |
$50.00 |
$50,000 |
D/D |
1,000 |
28,500 |
|
- |
|
| Young James F |
Director |
– • – |
2020-12-31 |
4 |
S |
$112.98 |
$1,244,015 |
D/D |
(11,000) |
0 |
|
- |
|
| Young James F |
Director |
– • – |
2020-12-31 |
4 |
OE |
$50.00 |
$564,000 |
D/D |
11,000 |
11,000 |
|
- |
|
| Erck Stanley C |
President and CEO |
• • – |
2020-11-16 |
4 |
AS |
$87.20 |
$4,742,667 |
D/D |
(52,316) |
20,495 |
|
- |
|
| Erck Stanley C |
President and CEO |
• • – |
2020-11-16 |
4 |
OE |
$25.60 |
$1,942,801 |
D/D |
52,317 |
72,811 |
|
- |
|
| Erck Stanley C |
President and CEO |
• • – |
2020-10-01 |
4 |
AS |
$108.57 |
$217 |
D/D |
(2) |
20,494 |
|
- |
|
| Trizzino John |
EVP, CBO and CFO |
• – – |
2020-09-30 |
4 |
AS |
$107.60 |
$248,002 |
D/D |
(2,250) |
5,087 |
|
- |
|
| Erck Stanley C |
President and CEO |
• • – |
2020-09-30 |
4 |
AS |
$107.56 |
$1,348,200 |
D/D |
(12,231) |
20,496 |
|
- |
|
| Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2020-09-29 |
4 |
AS |
$106.18 |
$1,934,667 |
D/D |
(18,029) |
275 |
|
- |
|
| Erck Stanley C |
President and CEO |
• • – |
2020-09-29 |
4 |
AS |
$106.22 |
$443,267 |
D/D |
(4,112) |
32,727 |
|
- |
|
| Trizzino John |
EVP, CBO and CFO |
• – – |
2020-09-29 |
4 |
AS |
$106.04 |
$1,965,630 |
D/D |
(18,321) |
7,337 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2020-09-29 |
4 |
AS |
$106.17 |
$2,134,844 |
D/D |
(19,949) |
1,561 |
|
- |
|
| Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2020-09-28 |
4 |
AS |
$107.22 |
$2,729,879 |
D/D |
(24,750) |
18,304 |
|
- |
|
| Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2020-09-28 |
4 |
OE |
$5.95 |
$147,263 |
D/D |
24,750 |
43,054 |
|
- |
|
| Erck Stanley C |
President and CEO |
• • – |
2020-09-28 |
4 |
AS |
$107.22 |
$2,757,456 |
D/D |
(25,000) |
36,839 |
|
- |
|
604 Records found
|
|
Page 12 of 25 |
|
|
